Zydus Lifesciences receives USFDA approval to manufacture Enzalutamide tablets, a generic prostate cancer treatment drug, for ...

Zydus Lifesciences share price will remain in focus on October 3 after the company received tentative approval from the ...

Zydus Lifesciences on Wednesday said it has received approval from the US health regulator to produce a generic prostate ...

Zydus Lifesciences on Wednesday said it has received approval from the US health regulator to produce a generic prostate ...

Ahmedabad: Zydus Lifesciences Limited has received tentative approval from the United States Food and Drug Administration ...

The company entered the OTC business in 2007 and it has grown to have established brands such as Manforce, HealthOK, Prega ...

BSE Healthcare index jumps by over 40% in first nine months of 2024: Sanjay Pingle, Mumbai Thursday, October 3, 2024, 08:00 Hrs [IST] The BSE Healthcare Index of 99 pharma and hea ...

"CSIR-CDRI's deep-rooted expertise in biomedical research, coupled with Zydus' innovative approach to drug discovery and ...

Zydus Lifesciences on Saturday said it has received approval from the US health regulator to produce generic prostate cancer ...

Zydus Lifesciences received an Establishment Inspection Report (EIR) from the USFDA for its Ahmedabad facility. Shares rose ...

Zydus Lifesciences has received a significant approval from the US FDA for Enzalutamide capsules, which are used in treatment ...

Ahmedabad: Zydus Lifesciences Ltd, Ahmedabad has signed a collaborative research agreement with Central Drug Research ...